ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 61 filers reported holding ADAGIO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $421,100 | +393451.4% | 382,818 | +1307.4% | 0.00% | – |
Q4 2023 | $107 | +28.9% | 27,200 | -44.2% | 0.00% | – |
Q3 2023 | $83 | +232.0% | 48,785 | +101.6% | 0.00% | – |
Q2 2023 | $25 | 0.0% | 24,200 | +18.0% | 0.00% | – |
Q1 2023 | $25 | +4.2% | 20,500 | +29.7% | 0.00% | – |
Q4 2022 | $24 | – | 15,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 9,248,250 | $15,722,025 | 18.03% |
Alphabet Inc. | 5,680,785 | $9,657,334 | 0.62% |
683 Capital Management, LLC | 4,000,000 | $6,800,000 | 0.53% |
Bain Capital Life Sciences Investors, LLC | 1,937,207 | $3,293,252 | 0.37% |
Acuitas Investments, LLC | 208,579 | $354,584 | 0.21% |
MAVERICK CAPITAL LTD | 5,270,290 | $8,959,493 | 0.20% |
Orbimed Advisors | 5,270,400 | $8,959,680 | 0.19% |
Slate Path Capital LP | 3,735,000 | $6,349,500 | 0.18% |
Redmile Group, LLC | 1,440,725 | $2,449,233 | 0.12% |
TANG CAPITAL MANAGEMENT LLC | 366,536 | $623,111 | 0.09% |